All News

Glutathione, also known as GSH, is a molecule found naturally in your body. It is produced by the liver and nerve cells in the...

April 12th, 2022 update. Discusses potentially halting the Study early due to positive efficacy based on other clinical outcomes evaluated such as the rate...

Calling a Super Bubble. | Front Row with Jeremy Grantham https://youtu.be/JlEGU2ypr1Q The Day of Reckoning is Here. Stagflation Will Shock the Markets! | Peter Schiff https://youtu.be/_c6Fv4BM-8c Fun (or...

Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE NEWS ARCHIVE INTRO “These medicines have a sweet spot. If the day you get diagnosed with COVID you...

"These medicines have a sweet spot. If the day you get diagnosed COVID you say 'forget it, I'll be fine,' and then several days...

Adding Revive Therapeutics (RVVTF, RVV.CN) to the "2022, Biotech 12 Pack, 12 Biotech Stocks We Expect to Double" Watch List*. If not our best ever,...

Demonstrates 100% Completion of Planned Treatment Cycles. Immix Biopharma, Inc. Wed, January 19, 2022. ImmixBio Announces Positive IMX-110 Phase 1b/2a Interim Clinical Trial Safety Data Demonstrating...

Michael Frank, CEO of the Company commented, "We are now in the final stages in our Phase 3 study.." Revive Therapeutics Provides Update on...

IRB approval to initiate Phase 2 study for methamphetamine abuse disordersAdvancing psilocybin oral thin film, microneedle patch and biosynthesis programs TORONTO, Jan. 17, 2022 (GLOBE...

Added to 12 Biotech Stocks we Expect to Double List. The Original Biotech 6-Pack from 2020, is Growing to a 12-Pack! Okay, here's our second...